Hydroxychloroquine (HCQ) or corticosteroid therapy showed a trend toward a negative correlation with the IFN-I score (PRKR, IFIT1, and IFI44) in PBMCs of SLE patients [ 4 ].
← all excerpts
Optimal Selection of IFN-α-Inducible Genes to Determine Type I Interferon Signature Improves the Diagnosis of Systemic Lupus Erythematosus.
1
—
—